Supporting people in hospitals across South Australia through vital health and medical research and improved patient care.
Meet our passionate and dedicated team.
Meet our Board and Governance team.
THRF adopts extremely high transparency standards when reporting our financials.
Supports research into the detection, management & treatment of breast cancer.
Funding research into prostate cancer prevention, detection & treatment.
Improving heart health through advances in knowledge & research to beat heart disease.
Our aim is to reduce & eliminate the high incidence of chronic kidney disease and diabetes.
Supports health and wellbeing research & programs for veterans, emergency service personnel and their families.
Driving collaboration, innovation & research to develop best-practice arts, design & health programs.
Supporting world-class stroke research to improve prevention, diagnosis & acute treatment to cure stroke.
Do you want to join our team? Check out current career opportunities here.
View some of the commonly asked questions about our organisation.
We are so grateful to those who donate their time and skills to support life-changing medical research. Find out more…
Get in touch with us here.
We are pleased to share the relocation of a prostate cancer machine, called a Bioruptor that was purchased thanks to your generous support of The Hospital Research Foundation is being relocated to the South Australian Health and Medical Research Institute (SAHMRI)!
The Bioruptor was previously purchased as a piece of equipment for a research team at the Basil Hetzel Institute for Translational Health Research (BHI). Due to a change in approach, the machine is being relocated to assist other prostate cancer researchers, including Associate Professor Lisa Butler.
Along with her team, including BHI’s Dr Irene Zinonos, A/Prof Butler is grateful for the relocation of the Bioruptor, which will vitally assist her research into prostate cancer. As the Bioruptor is able to blast prostate cancer cells and their DNA apart, this will allow A/Prof Butler and her team to analyse them more accurately and in minute detail.
“Having access to the Bioruptor, we can investigate the nature of the proteins that drive prostate cancer in tissue samples, and where they bind to DNA to switch on genes that allow cancer cells to survive and spread throughout the body,” A/Prof Butler said.
“Ultimately, this will help us determine which proteins are the best to target to better treat prostate cancer.”
Donate today to support more research like this.